| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
129,600
|
— | ₹1.10 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 2,296,000 |
100% | ₹19.52 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 129,600 | ₹1.10 |
5.64%
|
| Total | 2,296,000 | ₹19.52 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 3,200 | ₹272,000 |
| Retail (Max — 13 Lots) | 13 | 20,800 | ₹1,768,000 |
| S-HNI (Min — 14 Lots) | 14 | 22,400 | ₹1,904,000 |
| B-HNI (Min — 68 Lots) | 68 | 108,800 | ₹9,248,000 |
| Particulars | 31.03.2017 | 31.03.2016 | 31.03.2015 |
|---|---|---|---|
| Revenue from Operations | 4168.17 | 2639.47 | 26.24 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 426.92 | 76.57 | 11.00 |
| Net Worth | 738.04 | 220.09 | 106.70 |
| Total Assets | 2454.38 | 1520.37 | 800.91 |
| Reserves & Surplus | 637.04 | 119.09 | 5.71 |
| Borrowings | 751.64 | 751.64 | 751.64 |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Beta Drugs IPO is subscribed 1.00 times by Oct 04, 2017. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Beta Drugs IPO retail category is subscribed 1.00 times as of 04 Oct 2017. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 29 Sep 2017 and closes 04 Oct 2017. Min investment: ₹136,000 (1 lot = 1,600 shares). UPI mandate: 2017-10-04.
The Beta Drugs IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (LINK INTIME INDIA PRIVATE LIMITED) at https://www.linkintime.co.in. Enter your PAN, application number or DP/Client ID. Allotment date: 10 Oct 2017. Refunds: on 11 Oct 2017.
The Beta Drugs IPO listing date is 12 Oct 2017, Thursday. Listed on: NSE SME. Issue price: ₹85. Estimated listing: ₹97. GMP: +₹12.
The Beta Drugs IPO closes on 04 Oct 2017, Wednesday. UPI mandate: 2017-10-04. Allotment: 10 Oct 2017. Listing: 12 Oct 2017.